Titolo |
Pubblicato in |
Anno |
Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib |
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
2024 |
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule |
JOURNAL OF CONTEMPORARY BRACHYTHERAPY |
2022 |
Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to “cervix sparing” excision |
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES |
2021 |
Natural Cycle Results in Lower Implantation Failure than Ovarian Stimulation in Advanced-Age Poor Responders Undergoing IVF: Fertility Outcomes from 585 Patients |
REPRODUCTIVE SCIENCES |
2021 |
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2021 |
The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis |
CANCERS |
2021 |
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials |
CANCERS |
2021 |
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review |
JOURNAL OF CONTEMPORARY BRACHYTHERAPY |
2021 |
Effects of Endocrine-Disrupting Chemicals on Endometrial Receptivity and Embryo Implantation. A Systematic Review of 34 Mouse Model Studies |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2021 |
The treatment with levonorgestrel releasing intrauterine system (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois. clinical and ultrasonographic reports |
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES |
2021 |
Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives |
VACCINES |
2021 |
Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to “cervix sparing” excision |
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES |
2021 |
BRCA1 promoter methylation and clinical outcomes in ovarian cancer: an individual patient data meta-analysis |
JOURNAL OF THE NATIONAL CANCER INSTITUTE |
2020 |
Incorporating parp-inhibitors in primary and recurrent ovarian cancer. A meta-analysis of 12 phase II/III randomized controlled trials |
CANCER TREATMENT REVIEWS |
2020 |
Biological Impact of Unilateral Oophorectomy. Does the Number of Ovaries Really Matter?
[Biologische auswirkungen der einseitigen ovarektomie: Kommt es wirklich auf die anzahl der eierstöcke an?] |
GEBURTSHILFE UND FRAUENHEILKUNDE |
2020 |
Bevacizumab-based chemotherapy triggers Immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector T Cell Subsets |
JOURNAL OF CLINICAL MEDICINE |
2019 |
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2019 |
Low endometrial beta-catenin and cadherins expression patterns are predictive for primary infertility and recurrent pregnancy loss |
GYNECOLOGICAL ENDOCRINOLOGY |
2019 |
Current knowledge of miRNAs as biomarkers in breast cancer |
Recent trends in cancer biology: spotlight on signaling cascades and micrornas. Cell signaling pathways and micrornas in cancer biology |
2018 |
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer |
NEOPLASIA |
2018 |